There are currently no headlines for this stock.
The Company engages in the development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The Company operates over 30 GMP certified production lines and manufactures more than 240 different pharmaceutical products, including Western medicines and bulk medicines.
Industry: Drug Related Products
Other News & PR